Filing Details
- Accession Number:
- 0001179110-12-003335
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-23 16:02:31
- Reporting Period:
- 2012-02-21
- Filing Date:
- 2012-02-23
- Accepted Time:
- 2012-02-23 16:02:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1277478 | Glenn Sblendorio | 8 Sylvan Way Parsippany NJ 07054 | Executive Vp & Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-02-21 | 1,505 | $20.94 | 65,097 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-21 | 833 | $20.94 | 64,264 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-21 | 1,781 | $20.94 | 62,483 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-02-21 | 625 | $7.31 | 63,108 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-21 | 625 | $21.03 | 62,483 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option(right to buy) | Disposition | 2012-02-21 | 625 | $7.31 | 625 | $7.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,250 | 2020-02-19 | No | 4 | M | Direct |
Footnotes
- Represents the number of shares sold to cover the tax expense associated with the vesting of restricted shares held by Mr. Sblendorio pursuant to his Restricted Stock Agreements with the Company.
- As of 2/21/2012, the original grant (30,000 shares granted on 2/19/2010) was vested with respect to 15,000 of the shares covered thereby and the remaining 15,000 shares covered by this option vest in equal monthly installments ending on 2/19/2014. After the exercise of the options reported hereby, as of 2/21/2012, 1,250 of the shares covered by the option were vested but not exercised.
- The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Sblendorio on February 18, 2011.